OnKure Therapeutics (OKUR) Other financing activities (2020 - 2024)

OnKure Therapeutics (OKUR) has reported Other financing activities for 5 consecutive years, with $1000.0 the latest figure, recorded in Q4 2024.

• For the quarter ending Q4 2024, Other financing activities rose 100.26% year-over-year to $1000.0; the trailing twelve-month figure through Dec 2024 stood at $26000.0 (up 100.59% YoY), and the FY2025 full-year result was $240000.0, up 823.08% from the prior year.
• Other financing activities fell to $1000.0 in Q4 2024 per OKUR's latest filing, from $5000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $84.5 million in Q2 2021 and bottomed at -$4.2 million in Q3 2023.
• Historically, Other financing activities has averaged $5.4 million across 5 years, with a median of $10000.0 in 2020.
• The sharpest annual moves came in 2022 and 2023: Other financing activities soared 4750.0% in 2022, then sank 4442.27% in 2023.
• Over 5 years, Other financing activities stood at $10000.0 in 2020, then sank by 390.0% to -$29000.0 in 2021, then jumped by 555.17% to $132000.0 in 2022, then tumbled by 395.45% to -$390000.0 in 2023, then soared by 100.26% to $1000.0 in 2024.
• According to Business Quant data, Other financing activities over the past three periods registered $1000.0, $5000.0, and $10000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.